Literature DB >> 6758855

Comparison of low- and high-calcium-requiring forms of the calcium-activated protease with their autocatalytic breakdown products.

W R Dayton.   

Abstract

The effect of controlled autocatalytic degradation on the subunit molecular weight, subunit composition and calcium sensitivity of the low-calcium-requiring and the high-calcium-requiring forms of the calcium-activated muscle protease was examined. Purified low- and high-calcium-requiring proteases coelectrophorese on SDS-polyacrylamide gels. Controlled autocatalysis of either form of the protease results in extensive degradation of their respective 30 kDa subunits and partial degradation of their 80 kDa subunits. In this electrophoresis system the electrophoretic banding pattern of the low-calcium-requiring protease is clearly different from that of the autocatalytically degraded high-calcium-requiring protease. Similar results were obtained using a nondenaturing polyacrylamide gel system. Both the high- and low-calcium-requiring proteases were made more sensitive to calcium by autocatalytic degradation. However, the results of this study strongly indicate that autocatalytic degradation does not result in conversion of high-calcium-requiring protease to the low-calcium-requiring protease as has been recently hypothesized (Suzuki et al. (1981) J. Biochem. 90, 275-278).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758855     DOI: 10.1016/0167-4838(82)90457-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  The effects of autolysis on the structure of chicken calpain II.

Authors:  C Crawford; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

2.  Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies.

Authors:  J A Samis; G Zboril; J S Elce
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

3.  Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.

Authors:  Hanshuang Shao; Jeff Chou; Catherine J Baty; Nancy A Burke; Simon C Watkins; Donna Beer Stolz; Alan Wells
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Targeting individual calpain isoforms for neuroprotection.

Authors:  James W Geddes; Kathryn E Saatman
Journal:  Exp Neurol       Date:  2010-08-03       Impact factor: 5.330

5.  Ca2+-activated proteinase in the rat. Quantification by immunoassay in the uterus during pregnancy and involution, and in other tissues.

Authors:  J S Elce; J E Baenziger; D C Young
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

6.  Calpain inhibition by peptide epoxides.

Authors:  C Parkes; A A Kembhavi; A J Barrett
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

7.  Purification and characterization of calpain from human polymorphonuclear leukocytes.

Authors:  J L Legendre; H P Jones
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

8.  Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork.

Authors:  Bharathi Govindarajan; James Laird; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Biochemistry       Date:  2007-12-18       Impact factor: 3.162

9.  The atypical calpains: evolutionary analyses and roles in Caenorhabditis elegans cellular degeneration.

Authors:  Peter I Joyce; Rahul Satija; Maozi Chen; Patricia E Kuwabara
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.